NCT06232083 2025-07-09
A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
Anhui Provincial Hospital
Phase 1 Recruiting
Anhui Provincial Hospital
Anhui Provincial Hospital